• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA approves Roche’s Tecentriq Hybreza for cancer

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 13, 2024 at 10:26: AM
via The US Food and Drug Administration (FDA) has approved Roche's Tecentriq Hybreza, a subcutaneous anti-PD-(L)1 cancer immunotherapy.

The treatment offers a quicker and more comfortable administration option compared to the standard intravenous infusion.

article source
 




Similar threads

cafead
FDA approves Roche, Novartis' Xolair to prevent severe outcomes from common food allergies
Replies
0
Views
192
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA approves drugs from Gilead, Roche, TG Therapeutics to close 2022
Replies
0
Views
242
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Roche Wakes Up to New Competition as FDA Approves Amneal’s Avastin Biosimilar
Replies
0
Views
301
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA approves Roche’s Xofluza to prevent flu spreading in families
Replies
0
Views
389
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Replies
0
Views
122
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote